Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Vasc Surg. 2019 Feb 15;69(6):1924–1935. doi: 10.1016/j.jvs.2018.08.172

Figure 5. SG-1002 therapy increases collateral vessel number in ischemic hindlimbs.

Figure 5.

Contrast angiographic images were acquired at day 42 post-ALI in placebo (Figure 5A) and SG-1002 (Figure 5B) treated animals. Quantitative angiographic scoring of contrast-opacified vessels was higher in ischemic limbs of SG-1002 treated pigs compared to placebo ischemic limbs (Figure 5C). There was no difference in collateral vessel number in the nonischemic limbs between the placebo and SG-1002 groups. Values are means ± SEM with number of animals per group shown. NS, not significant.